Anzeige
Mehr »
Sonntag, 01.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
02.02.Freudenberg Medical Launches LUBRITEQ High-Performance Hydrophilic Coating
02.02.Piramal Pharma Solutions Introduces Tablet-in-Capsule Drug Delivery System
02.02.J&J 4Q Results
02.02.Alterome Therapeutics Appoints Leonardo Faoro as New CMO
02.02.Takeda Reshapes Leadership, Creates New Units Ahead of Fiscal 2026
02.02.Frontage Labs Expands Early Phase Clinical Capabilities
02.02.Quotient Therapeutics Appoints Susan Keefe as CFO
30.01.Lilly to Build New Pennsylvania Manufacturing Facility
30.01.Ardena Completes Divestment of Sweden Drug Substance Site to Nanologica
30.01.Merz Therapeutics Taps Dan Staner as President, Region Europe
30.01.Libris Innovations Taps Ramani Veranasi as CEO
29.01.New Veeva Application Eliminates Paper, Streamlines Clinical Trial Data Flow
29.01.Vetter to Build New Production Facility in Germany
29.01.Opentrons Formally Announces James Atwood as CEO
29.01.WuXi Biologics, Sinorda Biomedicine Partner to Advance SND006
29.01.IQVIA to Share its DaaS+ Platform in Boehringer Ingelheim Collaboration
29.01.Halozyme Acquires Surf Bio for up to $400M
29.01.Satellos Bioscience Taps Antoinette Paone as Chief Development Officer
28.01.Elysium Therapeutics Raises $7.5M to Advance Opioid Overdose Reversal Tech
28.01.Cellares Raises $257M to Industrialize Global Cell Therapy Manufacturing
28.01.Fujirebio Unveils CSF Assay to Assist Alzheimer's Research
28.01.Veranova Taps Former Alcami Exec as Chief Quality Officer
28.01.Halo Pharma Becomes Stand-Alone CDMO Business
28.01.Single Use Support Appoints Davy De Wilde as Chief Commercial Officer
27.01.Integrated Biosciences Names Daniel J. Anderson CSO